|
US382425A
(en)
|
|
1888-05-08 |
|
Brandt |
|
US2909462A
(en)
|
1955-12-08 |
1959-10-20 |
Bristol Myers Co |
Acrylic acid polymer laxative compositions
|
|
US4769331A
(en)
|
1981-09-16 |
1988-09-06 |
University Patents, Inc. |
Recombinant methods and materials
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US5505941A
(en)
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US5364773A
(en)
|
1991-03-07 |
1994-11-15 |
Virogenetics Corporation |
Genetically engineered vaccine strain
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US5833975A
(en)
|
1989-03-08 |
1998-11-10 |
Virogenetics Corporation |
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
|
|
US5338683A
(en)
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
|
US4745051A
(en)
|
1983-05-27 |
1988-05-17 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
|
US4552758A
(en)
|
1983-12-20 |
1985-11-12 |
St. Jude Children's Research Hospital |
Human use of avian-human reassortants as vaccines for influenza A virus
|
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
IE872748L
(en)
|
1986-10-16 |
1988-04-16 |
Arjomari Europ |
Polypeptides derived from the evvelope gene of human¹immunodeficiency virus in recombinant baculovirus infected¹insect cells
|
|
US6024983A
(en)
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
EP0386185A1
(fr)
|
1988-07-29 |
1990-09-12 |
IntraCel Corporation |
Procede d'expression genetique de proteines heterologues par des cellules transfectees in vivo
|
|
CA2003300A1
(en)
|
1988-11-21 |
1990-05-21 |
Franklin Volvovitz |
Skin test and test kit for aids
|
|
ATE240401T1
(de)
|
1989-03-21 |
2003-05-15 |
Vical Inc |
Expression von exogenen polynukleotidsequenzen in wirbeltieren
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5552143A
(en)
|
1989-03-24 |
1996-09-03 |
The Wistar Institute Of Anatomy & Biology |
Recombinant cytomegalovirus vaccine
|
|
US5591439A
(en)
|
1989-03-24 |
1997-01-07 |
The Wistar Institute Of Anatomy And Biology |
Recombinant cytomegalovirus vaccine
|
|
US5690938A
(en)
|
1989-07-07 |
1997-11-25 |
Oravax, Inc. |
Oral immunization with multiple particulate antigen delivery system
|
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
|
GB9001766D0
(en)
|
1990-01-25 |
1990-03-28 |
Univ Court Of The University O |
Vaccines
|
|
HK1004060A1
(en)
|
1990-04-24 |
1998-11-13 |
Flustat Pty Ltd |
Oral vaccine comprising antigen surface-associated with red blood cells
|
|
US5997878A
(en)
|
1991-03-07 |
1999-12-07 |
Connaught Laboratories |
Recombinant poxvirus-cytomegalovirus, compositions and uses
|
|
JP3602530B2
(ja)
|
1991-03-07 |
2004-12-15 |
ヴァイロジェネティクス コーポレイション |
遺伝子操作したワクチン菌株
|
|
ATE181108T1
(de)
|
1991-08-26 |
1999-06-15 |
Immuno Ag |
Direkt molekuläre klonierung eines modifizierten genoms eines chordopocken-virus
|
|
US5643578A
(en)
|
1992-03-23 |
1997-07-01 |
University Of Massachusetts Medical Center |
Immunization by inoculation of DNA transcription unit
|
|
US5807722A
(en)
|
1992-10-30 |
1998-09-15 |
Bioengineering Resources, Inc. |
Biological production of acetic acid from waste gases with Clostridium ljungdahlii
|
|
US5801029A
(en)
|
1993-02-16 |
1998-09-01 |
Onyx Pharmaceuticals, Inc. |
Cytopathic viruses for therapy and prophylaxis of neoplasia
|
|
IL108915A0
(en)
|
1993-03-18 |
1994-06-24 |
Merck & Co Inc |
Polynucleotide vaccine against influenza virus
|
|
FR2711670B1
(fr)
|
1993-10-22 |
1996-01-12 |
Pasteur Institut |
Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
|
|
EP1170368B1
(en)
|
1994-01-27 |
2010-07-28 |
University Of Massachusetts Medical Center |
Immunization by inoculation of dna transcription unit
|
|
ATE298370T1
(de)
|
1994-04-29 |
2005-07-15 |
Baxter Healthcare Sa |
Rekombinante poxviren mit fremdenpolynukleotiden in wichtigen regionen
|
|
US5928913A
(en)
|
1995-03-23 |
1999-07-27 |
Efstathiou; Stacey |
Vectors for gene delivery
|
|
EP0979101B1
(en)
|
1996-07-03 |
2010-10-27 |
Merial, Inc. |
Recombinant canine adenovirus 2 (cav2) containing exogenous dna
|
|
US6183752B1
(en)
|
1997-02-05 |
2001-02-06 |
Pasteur Merieux Serums Et Vaccins |
Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
|
|
US6204281B1
(en)
|
1998-07-10 |
2001-03-20 |
Novartis Ag |
Method of treatment and pharmaceutical composition
|
|
CN100489107C
(zh)
|
2000-04-28 |
2009-05-20 |
圣朱德儿童研究医院 |
用于产生感染性流感病毒的dna转染系统
|
|
US20020095197A1
(en)
|
2000-07-11 |
2002-07-18 |
Lardo Albert C. |
Application of photochemotherapy for the treatment of cardiac arrhythmias
|
|
JPWO2002062381A1
(ja)
|
2001-02-05 |
2004-06-03 |
久光製薬株式会社 |
バキュロウイルスベクターワクチン
|
|
CA2456034A1
(en)
|
2001-08-03 |
2003-02-20 |
Takeda Chemical Industries, Ltd. |
Sustained-release medicines
|
|
JP2005539039A
(ja)
*
|
2002-08-27 |
2005-12-22 |
ダウ アグロサイエンシィズ エルエルシー |
鳥類及び家禽類におけるアジュバントとしてのエシェリシア・コリ熱不安定性毒素の使用
|
|
US7566458B2
(en)
|
2003-06-16 |
2009-07-28 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
|
US8080255B2
(en)
|
2003-07-11 |
2011-12-20 |
Novavax Inc. |
Functional influenza virus like particles (VLPs)
|
|
DE202005022108U1
(de)
|
2004-03-09 |
2013-11-12 |
Novartis Vaccines And Diagnostics, Inc. |
Influenza-Virus-Impfstoffe
|
|
EP1766059B1
(en)
|
2004-05-25 |
2012-07-11 |
MedImmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
|
CN1748795A
(zh)
|
2004-09-17 |
2006-03-22 |
金宁一 |
多价禽流感重组活载体疫苗
|
|
EP1877088B1
(en)
|
2005-04-11 |
2014-12-17 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Vaccine against pandemic strains of influenza viruses
|
|
US7871626B2
(en)
|
2005-08-04 |
2011-01-18 |
St. Jude Children's Research Hospital |
Modified influenza virus for monitoring and improving vaccine efficiency
|
|
TWI488968B
(zh)
*
|
2005-10-18 |
2015-06-21 |
Novavax Inc |
功能性流行性感冒類病毒顆粒（ＶＬＰｓ）
|
|
CA2626866A1
(en)
*
|
2005-10-28 |
2007-05-10 |
Boehringer Ingelheim Vetmedica, Inc. |
Use of vaccines for the treatment/ prevention of the transmission of influenza pathogens between species
|
|
US20100150941A1
(en)
*
|
2006-09-13 |
2010-06-17 |
Dso National Laboratories |
Hemagglutinin antibody and uses thereof
|
|
CL2007003102A1
(es)
*
|
2006-10-27 |
2008-04-18 |
Boehringer Ingelheim Vetmed |
Proteina h5 del virus de la gripe; molecula de acido nucleico que la codifica; metodo de produccion; vacuna que la comprende y su metodo de produccion; y su uso para tratar la gripe viral.
|
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
|
US7981428B2
(en)
|
2008-01-23 |
2011-07-19 |
Academia Sinica |
Flu vaccines and methods of use thereof
|
|
WO2011136738A1
(en)
|
2010-04-30 |
2011-11-03 |
Temasek Life Sciences Laboratory Limited |
Universal vaccine against h5n1 lineages
|
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
|
MX360137B
(es)
|
2013-02-21 |
2018-10-24 |
Boehringer Ingelheim Vetmedica Gmbh |
Proteínas h5 del virus de la influenza h5n1 para usarse como un medicamento.
|